YAP1 and cholangiocarcinoma: For example, YAP and TAZ were reported to suppress bone angiogenesis by constraining hypoxia-inducible factor signalling in ECs159; YAP was shown to promote angiogenesis in human cholangiocarcinoma through TEAD transcription factors147.